These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 277084

  • 1. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
    Murphy S, Davis JL, Walsh PN, Gardner FH.
    Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
    Laharrague PF, Corberand JX, Fillola G, Boneu BP, Pris JF.
    Biomed Pharmacother; 1984 Aug; 38(9-10):462-5. PubMed ID: 6597727
    [Abstract] [Full Text] [Related]

  • 3. Platelet survival, platelet factor-4 and bleeding time in myeloproliferative disorders.
    Berild D, Hasselbalch H, Knudsen JB.
    Scand J Clin Lab Invest; 1987 Sep; 47(5):497-501. PubMed ID: 3477851
    [Abstract] [Full Text] [Related]

  • 4. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
    Tangün Y.
    Thromb Diath Haemorrh; 1971 Jun 30; 25(2):241-51. PubMed ID: 5284903
    [No Abstract] [Full Text] [Related]

  • 5. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders.
    Brodsky I, Kahn SB, Ross EM, Petkov G.
    Cancer; 1972 Dec 30; 30(6):1444-50. PubMed ID: 4509103
    [No Abstract] [Full Text] [Related]

  • 6. Spontaneous platelet aggregation in myeloproliferative disorders. A preliminary study.
    Barbui T, Battista R, Dini E.
    Acta Haematol; 1973 Dec 30; 50(1):25-9. PubMed ID: 4200801
    [No Abstract] [Full Text] [Related]

  • 7. Platelet defects in the myeloproliferative disorders.
    Inceman S, Tangün Y.
    Ann N Y Acad Sci; 1972 Oct 27; 201():251-61. PubMed ID: 4509685
    [No Abstract] [Full Text] [Related]

  • 8. [Megakaryocytopoiesis in myeloproliferative disorders].
    Podolak-Dawidziak M.
    Acta Haematol Pol; 1992 Oct 27; 23(2 Suppl 1):19-22. PubMed ID: 1488868
    [No Abstract] [Full Text] [Related]

  • 9. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders.
    Wehmeier A, Südhoff T, Meierkord F.
    Semin Thromb Hemost; 1997 Oct 27; 23(4):391-402. PubMed ID: 9263357
    [Abstract] [Full Text] [Related]

  • 10. Platelets in the myeloproliferative syndrome.
    Weinfeld A, Branehög I, Kutti J.
    Clin Haematol; 1975 Jun 27; 4(2):373-92. PubMed ID: 1102193
    [No Abstract] [Full Text] [Related]

  • 11. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
    Boneu B, Nouvel C, Sie P, Caranobe C, Combes D, Laurent G, Pris J, Bierme R.
    Scand J Haematol; 1980 Sep 27; 25(3):214-20. PubMed ID: 7466310
    [Abstract] [Full Text] [Related]

  • 12. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder.
    Handa M, Watanabe K, Kawai Y, Kamata T, Koyama T, Nagai H, Ikeda Y.
    Thromb Haemost; 1995 Mar 27; 73(3):521-8. PubMed ID: 7667837
    [Abstract] [Full Text] [Related]

  • 13. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis.
    Mindner K, Ostermann G, Hochhaus A, Höche D, Till U.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Mar 27; 115(4):461-4. PubMed ID: 2465953
    [Abstract] [Full Text] [Related]

  • 14. Platelet function and arachidonate metabolism in patients with myeloproliferative disorders.
    Okuma M.
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec 27; 43(6):1139-44. PubMed ID: 6800179
    [No Abstract] [Full Text] [Related]

  • 15. Platelet function in patients with high platelet counts.
    Ginsburg AD.
    Ann Intern Med; 1975 Apr 27; 82(4):506-11. PubMed ID: 1054537
    [Abstract] [Full Text] [Related]

  • 16. Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders.
    Pareti FI, Gugliotta L, Mannucci L, Guarini A, Mannucci PM.
    Thromb Haemost; 1982 Apr 30; 47(2):84-9. PubMed ID: 7101243
    [Abstract] [Full Text] [Related]

  • 17. [Hemostasis disorders with reduced activity of the von Willebrand factor in myeloproliferative syndromes].
    Leupin L, Beck EA, Furlan M, Bucher U.
    Schweiz Med Wochenschr; 1983 May 14; 113(19):713-6. PubMed ID: 6603016
    [Abstract] [Full Text] [Related]

  • 18. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.
    Barbui T, Cortelazzo S, Viero P, Bassan R, Dini E, Semeraro N.
    Eur J Cancer Clin Oncol; 1983 Nov 14; 19(11):1593-9. PubMed ID: 6580171
    [Abstract] [Full Text] [Related]

  • 19. Evidence for a platelet membrane defect in the myeloproliferative syndromes.
    Castaldi PA, Berndt MC, Booth W, Gregory C, Bull H, Greaves M.
    Thromb Res; 1982 Sep 01; 27(5):601-9. PubMed ID: 6960545
    [Abstract] [Full Text] [Related]

  • 20. The role of platelets in the pathogenesis of thrombosis and hemorrhage in patients with thrombocytosis.
    Walsh PN, Murphy S, Barry WE.
    Thromb Haemost; 1977 Dec 15; 38(4):1085-96. PubMed ID: 579686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.